| 1 |
35053615 | CD26/DPP4 as a Therapeutic Target in Nonalcoholic Steatohepatitis Associated Hepatocellular Carcinoma. | 2022 Jan 17 |
2 |
| 2 |
31866290 | Rapid detection of DPP-IV activity in porcine serum: A fluorospectrometric assay. | 2020 Mar 1 |
2 |
| 3 |
29806214 | Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection. | 2019 Jan |
2 |
| 4 |
30255759 | Combined Ligand-Based and Structure-Based Virtual Screening Approach for Identification of New Dipeptidyl Peptidase 4 Inhibitors. | 2019 |
2 |
| 5 |
31357088 | CD26 in autoimmune diseases: The other side of "moonlight protein". | 2019 Oct |
2 |
| 6 |
29426867 | Crystal structures of a bacterial dipeptidyl peptidase IV reveal a novel substrate recognition mechanism distinct from that of mammalian orthologues. | 2018 Feb 9 |
3 |
| 7 |
28630069 | Degradation of Incretins and Modulation of Blood Glucose Levels by Periodontopathic Bacterial Dipeptidyl Peptidase 4. | 2017 Sep |
2 |
| 8 |
26919392 | Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system. | 2016 Jul |
5 |
| 9 |
26988064 | Identifying neuropeptide Y (NPY) as the main stress-related substrate of dipeptidyl peptidase 4 (DPP4) in blood circulation. | 2016 Jun |
3 |
| 10 |
27431629 | [Development of New Therapy for Malignant Mesothelioma Based on CD26 Molecule]. | 2016 Jul |
1 |
| 11 |
25723507 | Mechanisms of neurodegeration in type 2 diabetes and the neuroprotective potential of dipeptidyl peptidase 4 inhibitors. | 2015 |
2 |
| 12 |
24516103 | Substance P increases sympathetic activity during combined angiotensin-converting enzyme and dipeptidyl peptidase-4 inhibition. | 2014 May |
1 |
| 13 |
25140306 | The nonglycemic actions of dipeptidyl peptidase-4 inhibitors. | 2014 |
2 |
| 14 |
25216328 | Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors. | 2014 Dec |
1 |
| 15 |
25360654 | [Effects of dipeptidyl peptidase-4 on the hematopoiesis and transplantation]. | 2014 Oct |
2 |
| 16 |
23579020 | Interaction of dipeptydil peptidase IV with amyloid peptides. | 2013 Jun |
2 |
| 17 |
23637126 | Implications of DPP4 modification of proteins that regulate stem/progenitor and more mature cell types. | 2013 Jul 11 |
1 |
| 18 |
23677473 | Dipeptidyl peptidase IV is a human and murine neutrophil chemorepellent. | 2013 Jun 15 |
1 |
| 19 |
22561447 | Dipeptidyl peptidase-4 expression is reduced in Crohn's disease. | 2012 Aug 20 |
2 |
| 20 |
21510839 | Current advances and therapeutic potential of agents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast activation protein. | 2011 |
2 |
| 21 |
19217790 | Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes. | 2009 Mar 1 |
1 |
| 22 |
19806507 | Albiglutide, an albumin-based fusion of glucagon-like peptide 1 for the potential treatment of type 2 diabetes. | 2009 Oct |
2 |
| 23 |
17300591 | Dipeptidyl peptidase-IV inhibitors: a major new class of oral antidiabetic drug. | 2007 Mar |
1 |
| 24 |
17676345 | 3D-QSAR studies of Dipeptidyl peptidase IV inhibitors using a docking based alignment. | 2007 Oct |
2 |
| 25 |
16913724 | Design and discovery of a novel dipeptidyl-peptidase IV (CD26)-based prodrug approach. | 2006 Aug 24 |
1 |
| 26 |
14691230 | N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding. | 2004 Jan |
1 |
| 27 |
12800091 | Degradation, cyclic adenosine monophosphate production, insulin secretion, and glycemic effects of two novel N-terminal Ala2-substituted analogs of glucose-dependent insulinotropic polypeptide with preserved biological activity in vivo. | 2003 Jun |
2 |
| 28 |
14664713 | Novel dipeptidyl peptidase IV resistant analogues of glucagon-like peptide-1(7-36)amide have preserved biological activities in vitro conferring improved glucose-lowering action in vivo. | 2003 Dec |
2 |
| 29 |
11832466 | Biological actions and therapeutic potential of the glucagon-like peptides. | 2002 Feb |
2 |
| 30 |
10913301 | Structural determinants for activity of glucagon-like peptide-2. | 2000 Aug 1 |
1 |
| 31 |
15016242 | Synthesis, secretion and biological actions of the glucagon-like peptides. | 2000 Mar |
1 |
| 32 |
10024091 | Long-lasting antidiabetic effect of a dipeptidyl peptidase IV-resistant analog of glucagon-like peptide-1. | 1999 Feb |
1 |
| 33 |
9149329 | Lower serum dipeptidyl peptidase IV activity in treatment resistant major depression: relationships with immune-inflammatory markers. | 1997 Feb |
2 |
| 34 |
9183643 | Role of CD26 for CD4 memory T cell function and activation. | 1996 Sep |
1 |
| 35 |
7911611 | Dipeptidyl peptidase IV: development, design, synthesis and biological evaluation of inhibitors. | 1994 |
3 |
| 36 |
8100523 | Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum. | 1993 Jun 15 |
4 |